Thus, the exact role of GLP-1R in liraglutide-mediated ferroptosis inhibition and NAFLD treatment remains further exploration, in which GLP-1R deficient mouse could be an powerful tool to solve this question. The gene discussed is GLP1R; the disease is metabolic dysfunction-associated steatotic liver disease.